TH‐302: A Highly Selective Hypoxia‐Activated Prodrug for Treating PARP Inhibitor–Resistant Cancers

Xiaobo Cheng & Yu Kang et al. · 2024

Links
Authors
Xiaobo Cheng, Jing Xu, Fanying Meng, Tianyang Qi, Xiaotong Wang, Ranran Chai, Chong Lu, Guanqin Jin, Kewei Zheng, Xing Liu, Yizhi Wang, Xiaohong Cai, Zhaoqiang Lu, Jibing Yu, Meizhen Ruan, Jinwei Fan, Wei Qin, Qunhui Huang, Yanjun Zhang, Anrong Li, Jianxin Duan, Yu Kang